Anterior Lens Capsule Versus Mitomycin-C as an Adjunct to Trabeculectomy in Combined Phacotrabeculectomy

Emarah, Ahmed M; El-Helw, Mostafa A

doi:10.1097/ijg.0b013e3181efe1d5

Search citation statements

Order By: Relevance

Paper Sections

Select...

Application Of Alc In Glaucoma1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2013

2020

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Therefore, we infer the biodegradation of ALC in vivo may occur between 1 and 3 months. Besides our study, several other studies also confirmed the efficacy and safety of ALC transplantation in phacotrabeculectomy (Emarah & El-Helw 2011;Das et al 2018) or phacoemulsification-deep sclerectomy (Rekas et al 2010) thereafter.…”

Section: Application Of Alc In Glaucomasupporting

confidence: 85%

Anterior lens capsule: biomechanical properties and biomedical engineering perspectives

Huang

Guo

et al. 2020

Acta Ophthalmologica

View full text Add to dashboard Cite

Anterior lens capsule, as the thickest basement membrane in the body, has its unique physiology characteristics. In ophthalmology, many attempts have been made to culture different kinds of cells including iris pigment epithelial cells, retinal pigment epithelial cells, corneal epithelium and endothelium cells, trabecular meshwork cells etc and anterior lens capsule has been confirmed to be served as an excellent scaffold for the growth and expansion of different ocular cells. Furthermore, anterior lens capsule also has unique potential in gestation evaluation and the treatment of various ocular diseases, including corneal ulcer, glaucoma, age-related macular degeneration and macular hole, etc. Here, we provide an overview of the biomechanical properties and biomedical engineering perspectives of anterior lens capsule.

show abstract

Section: Application Of Alc In Glaucomasupporting

confidence: 85%